Intention to treat (ITT) means (standard deviations) for outcome and process measures for all participants in the ACT (n = 52) and waitlist control (n = 46) groups. by Arianna Prudenzi (12436789)

Subjects:

Participants flow. by Arianna Prudenzi (12436789)

Subjects:

Statistically significant linear decrease in use of antidepressants, antipsychotics, psychostimulants and nootropic drugs, anxiolytics, sedatives and hypnotics during the observed time period. by Jelena Filimonovic (22305307)

ANCOVA of the primary endpoint: Tinnitus Questionnaire (TQ) sum score (baseline based multiple imputation). by Uso Walter (16949243)

Subjects:

Mindfulness-based stress reduction interventions. by Xiaoli Liu (165371)

Subjects:

Clinical outcomes. by Domenico Maurizio Toraldo (9071920)

Subjects:

Estrogen reduction changed the structure of gut microbiota in OH model mice. by Limin Liu (201430)

Subjects:

Multiple linear regression analysis of the RAAS system and glucose metabolism indexes in HT and NT patients. by Ningning Wang (560944)

Subjects:

Significant interactions from mixed linear models of ECM colonization (Table 1). by Laura García de Jalón (8939456)

Change of the primary endpoint Tinnitus Questionnaire (TQ) sum score based on the intention to treat (ITT) population of patients (imputation: multiple imputations). by Uso Walter (16949243)

Subjects:

Linear regression. by Myriam Aïche (22290591)

Clinical and demographic characteristics of the patients (n = 280). by Phuong Nguyen Thi Thu (11503489)

Subjects:

Multivariable linear regression analyses for predicting factors. by Maurice Pradella (11678817)

Subjects:

Decreased brain-derived neurotrophic factor plasma levels in psoriasis patients by A.R. Brunoni (5694239)

“…After adjusting for clinical and demographic variables, significantly decreased BNDF plasma levels were observed in psoriasis patients (P=0.01) (estimated marginal means of 3922 pg/mL; 95%CI=2660-5135) compared with controls (5788 pg/mL; 95%CI=5185-6442). …”

Baseline maternal and infant demographics and clinical characteristics. by Ashenafi Shumey Cherkos (19434556)

Subjects:

Join-point regression analysis of the statistically significant linear increase in use of antidepressants during the observed time period. by Jelena Filimonovic (22305307)

Sample size estimation based on preliminary date. by Jacquelyn Y. Taylor (6386456)

Subjects:

Fitted estimates and significance levels of linear mixed models for seedling germination, survival and growth. by Laura García de Jalón (8939456)

Descriptive statistics of outcomes at baseline, post-intervention, and follow-up and estimates of the linear mixed effects model for the outcomes. by Ana Beato (20489933)

Subjects:

Modelling the significance of prevalence reduction from pre- to post-intervention surveys. by Kareen Atekem (14290058)

Subjects: